Skip to main content
PALATIN TECHNOLOGIES INC logo

PALATIN TECHNOLOGIES INC — Investor Relations & Filings

Ticker · PTN ISIN · US6960776010 LEI · 549300IDN7TWMQI0JP93 Manufacturing
Filings indexed 75 across all filing types
Latest filing 2025-11-06 Regulatory Filings
Country US United States of America
Listing PTN

About PALATIN TECHNOLOGIES INC

https://palatin.com/

Palatin Technologies Inc. is a biopharmaceutical company focused on discovering and developing novel therapeutics. The company leverages deep expertise in receptor pharmacology and peptide/small-molecule design to modulate the melanocortin receptor (MCR) system. This system plays a crucial role in regulating appetite, energy homeostasis, inflammation, and immune response. Palatin's approach involves developing highly selective melanocortin agonists, targeting specific receptor subtypes like MC1R and MC4R, to address complex, multifactorial diseases. Their primary therapeutic areas include obesity, with a particular emphasis on rare neuroendocrine disorders such as hypothalamic obesity and Prader-Willi syndrome, as well as various inflammatory and autoimmune conditions. Palatin aims to develop first-in-class medicines to meet significant unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings
2025-11-06 English
FORM S-1/A
Registration Form
2025-10-17 English
S-1/A
Registration Form
2025-10-01 English
FORM S-1
Registration Form
2025-10-01 English
FORM 10-K
Annual Report
2025-09-23 English
FORM 8-K
Regulatory Filings
2025-09-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.